As an assistant professor at Perelman School of Medicine at the University of Pennsylvania, Emily Largent focuses primarily on research ethics and issues surrounding Alzheimer’s disease.
In this episode, you will discover:
Over 5.5 million Americans have dementia, and there is still no disease-modifying therapy and no way to reverse or slow the progression of the disease. It is one of the most feared conditions of old age because it affects people’s personal identity, sense of self, and personal relationships in a way no other disease can.
Largent discusses the key premise of her research, which is that our understanding of Alzheimer’s disease is changing in ways that will have a fundamental impact on the lived experiences of those who receive the diagnosis, as well as their family members. Largent is interested in exploring the social, legal, and ethical implications of Alzheimer’s disease research and how to translate this research into high-quality bedside care.
In addition, she is interested in better understanding how people receive the news that they are (or are not) at a greater risk of developing Alzheimer’s disease in the future. She expounds on the details of a particular study which aimed to identify the emotional impact of receiving this type of news, and shares some interesting findings. She also discusses the ways in which people respond practically to receiving such news, and explores how it might affect the relationships they have with other people.
Tune in to hear the full conversation. To learn more, visit https://www.alz.org/, https://www.nia.nih.gov/, and https://pennmemorycenter.org/.
Available on Apple podcast: apple.co/2Os0myK
Podcast: Play in new window | Download | Embed
Subscribe to Our Newsletter
Get The Latest Finding Genius Podcast News Delivered To Your Inbox